FindTrial
Sign In

Effects of Transversus Abdominis Plain Block on Remifentanil and Propofol Consumption Evaluated by Closed-Loop Titration Guided by Bispectral Index

Effects of Transversus Abdominis Plain Block on Remifentanil and Propofol Consumption Evaluated by Closed-Loop Titration Guided by Bispectral Index

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17014111
Enrollment
Unknown
Registered
2017-12-24
Start date
2018-03-01
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon cancer

Interventions

CON group:TAP block with 20mL normal saline
TAP group:TAP block with 20 mL of ropivacaine 0.375%

Sponsors

The Affiliated Yantai Yuhuangding Hospital of Qingdao Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
37 Years to 74 Years

Inclusion criteria

Inclusion criteria: 60 ASA I-II patients (aged 37-74years, weighted 53-84 kg) scheduled for laparoscopic radical operation on colon under general anaesthesia were registered.

Exclusion criteria

Exclusion criteria: Patients were excluded if they had a history of allergy to the drugs used in this study, psychological disorders, infection of the block injection site or any other contraindications for TAP block, tolerance to opioids or if they had used opioids within 48 h prior to the study.

Design outcomes

Primary

MeasureTime frame
Propofol consumption;Rifentanyl consumption;—

Secondary

MeasureTime frame
hypertensive and hypotensive events;recovery time;time to first rescue analgesia after surgery.;—

Countries

China

Contacts

Public ContactMa Jiahai
mjh-214@126.com+86 13656456186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026